Company SinoMab BioScience Limited

3681

HK0000544194

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Biopharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:21:27 26/06/2024 pm IST			5-day change	1st Jan Change
1.75 ^HKD	+2.94%		+2.94%	+4.17%

13/06	Hong Kong Stocks Bounce Back as US Inflation Data Comes in Lower Than Expected	MT
13/06	Sinomab Bioscience Administers First Dose of Atopic Dermatitis Drug	MT

SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Companyâs product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogrenâs syndrome (SS) and other immunological diseases.

Number of employees: 215

Managers	Title	Age	Since
Shui On Leung CEO	Chief Executive Officer	64	27/01/27
Jian Ping Hua DFI	Director of Finance/CFO	42	01/19/01
Li Xin Zhang CTO	Chief Tech/Sci/R&D Officer	60	01/21/01
Shan Chun Wang BRD	Director/Board Member	56	01/22/01
Ka Wa Benny Cheung PRN	Corporate Officer/Principal	44	01/10/01
Kwan Yin Siu PRN	Corporate Officer/Principal	45	-
Ming Hon Yau PRN	Corporate Officer/Principal	45	01/12/01
Yuk Yin Chow SEC	Corporate Secretary	53	31/23/31

Members of the board	Title	Age	Since
Dylan Tinker BRD	Director/Board Member	55	31/19/31
Ping Cho Hon BRD	Director/Board Member	64	31/19/31
Hai Gang Chen BRD	Director/Board Member	41	01/17/01
Shan Chun Wang BRD	Director/Board Member	56	01/22/01
Chi Ming Lee BRD	Director/Board Member	70	15/21/15
Wenyi Liu BRD	Director/Board Member	37	01/17/01
Shui On Leung CEO	Chief Executive Officer	64	27/01/27
George William Hunter Cautherley BRD	Director/Board Member	81	23/19/23
Xun Dong BRD	Director/Board Member	50	23/19/23
Lei Shi BRD	Director/Board Member	38	17/21/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,091,755,119	412,298,663 ( 37.76 %)	0	37.76 %

Name	Equities	%	Valuation
Shanghai Xingze Investment Management Co. Ltd. 16.55 %	180,665,600	16.55 %	43 M $
CHINA CITIC BANK CORPORATION LIMITED 14.55 %	158,882,115	14.55 %	38 M $
Shui On Leung 11.88 %	129,729,200	11.88 %	31 M $
Si Jia Xu 8.225 %	89,802,105	8.225 %	21 M $
Jing Qiang 6.670 %	72,823,636	6.670 %	17 M $
YUNNAN BAIYAO GROUP CO.,LTD 4.613 %	50,357,700	4.613 %	12 M $
Shan Chun Wang 3.248 %	35,464,800	3.248 %	8 M $
Wenyi Liu 1.825 %	19,923,000	1.825 %	5 M $

Sinomab Bioscience Ltd.

Hong Kong Science Park, Pak Shek Kok No.15 Science Park West Avenue

, Hong Kong

http://www.sinomab.com

address SinoMab BioScience Limited(3681)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
SINOMAB BIOSCIENCE LIMITED	+4.17%	238M
CSL LIMITED	+2.87%	94.22B
SAMSUNG BIOLOGICS CO.,LTD.	-3.42%	37.76B
BIOGEN INC.	-13.75%	32.5B
UCB	+74.33%	27.75B
BIOMARIN PHARMACEUTICAL INC.	-11.88%	16.13B
INCYTE CORPORATION	+0.49%	14.19B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.95%	11.42B
ALTEOGEN INC.	+190.36%	11.06B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54.07%	9.09B

Biopharmaceuticals